ANDRA BRIGHT: Open Payments
NPI 1952903650 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 8 payments from 7 companies in 2025. Trend: 2023 $1,831 · 2024 $944 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: INGREZZA, CAPLYTA, ARISTADA, INVEGA SUSTENNA, VRAYLAR, UZEDY, COBENFY.
Industry payments across AL — which companies pay providers there.
